THE EFFECT OF SELECTED COFFEE CONSTITUENTS ON MITOCHONDRIAL DYSFUNCTION IN AN EARLY ALZHEIMER DISEASE CELL MODEL
Abstract
Alzheimer disease (AD) is an emerging medical problem worldwide without any cure yet. By 2050, more than 152 million people will be affected. AD is characterized by mitochondrial dys-function (MD) and increased amyloid beta (A{beta}) levels. Coffee is one of the most commonly consumed beverages. It has many bioactive and neuroprotective ingredients of which caffeine (Cof), kahweohl (KW) and cafestol (CF) shows a variety of pharmacological properties such as anti-inflammatory and neuroprotective effects. Effects of Cof, KW, and CF were tested in a cel-lular model of AD on MD and A{beta}. SH-SY5Y-APP695 cells were incubated with 50{micro}M Cof, 1{micro}M CF and 1{micro}M KW for 24h. The energetic metabolite ATP was determined using a luciferase-catalyzed bioluminescence assay. The activity of mitochondrial respiration chain complexes was assessed by high-resolution respirometry using a Clarke electrode. Expression levels genes were deter-mined using quantitative real-time polymerase chain reaction (qRT-PCR). The levels of amyloid {beta}-protein (A{beta}1-40) were measured using homogeneous time-resolved fluorescence (HTRF). ROS levels, cAMP levels, and peroxidase activity were determined using a fluorescence assay. The combination of Cof, KW and CF significantly increased ATP levels. The combination had neither a significant effect on MMP, on activity of respiration chain complexes, nor on A{beta}1-40 levels. cAMP levels were slightly increased after incubation with the combination, but not the peroxi-dase activity. Pyruvate levels and the lactate-pyruvate-ration but not lactate levels were signifi- cantly enhanced. No effect was seen on the expression level of lactate dehydrogenase and py-ruvate dehydrogenase kinase. In some experiments we have tested the single substances. They showed significant results especially in ATP, lactate and pyruvate values compared to the con-trol. The combinations have a lesser effect on mitochondrial dysfunction in cells and none on A{beta} production. Whereas ATP levels and pyruvate levels were significantly increased. This suggests a change in glycolysis in neuronal cells harbouring human genes relevant for AD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Combination of secondary plant metabolites and micronutrients against Alzheimer disease in a SH-SY5Y-APP695 cell model
Lukas Babylon, Julia Meißner, Gunter Peter Eckert·bioRxiv·Apr 24, 2023
- Association of cytochrome c oxidase dysfunction with amyloidosis in Alzheimer's disease and patient-derived cerebral organoids
Tienju Wang, Yanting Chen, … Heng Du·OrganellePeer-reviewed·Jun 23, 2026
- Mitochondrial Dysfunction in Alzheimer's Disease Is Driven By Excess ER-Calcium Release in Patient-Derived Neurons
Sarah Mustaly-Kalimi, Wacey Gallegos, … Grace E. Stutzmann·bioRxiv·Oct 11, 2024
- Mitochondrial Complex I Modulator Restores Network Resilience in Advanced Alzheimer's Disease Through Metabolic Reprogramming
Esraa Gabal, Thi Kim Oanh Nguyen, … Eugenia V. Trushina·bioRxiv·Jun 17, 2026
- Discovery and Preclinical Validation of a Clinically Optimized Mitochondrial Complex I Modulator for Alzheimer's Disease
Sergey Trushin, Thi Kim Oanh Nguyen, … Eugenia V. Trushina·bioRxiv·Apr 14, 2026
- Therapeutic assessment of a novel mitochondrial complex I inhibitor in in vitro and in vivo models of Alzheimer's disease
Sergey Trushin, Thi Kim Oanh Nguyen, … Eugenia V. Trushina·EBioMedicinePeer-reviewed·Sep 17, 2025